AC Immune (ACIU) Assets Average (2017 - 2025)
AC Immune (ACIU) has disclosed Assets Average for 8 consecutive years, with $234.8 million as the latest value for Q4 2024.
- On a quarterly basis, Assets Average rose 17.69% to $234.8 million in Q4 2024 year-over-year; TTM through Dec 2024 was $234.8 million, a 17.69% increase, with the full-year FY2024 number at $233.6 million, up 17.24% from a year prior.
- Assets Average was $234.8 million for Q4 2024 at AC Immune, up from $199.6 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $283.2 million in Q4 2020 to a low of $199.6 million in Q4 2023.
- A 5-year average of $245.9 million and a median of $238.3 million in 2022 define the central range for Assets Average.
- Peak YoY movement for Assets Average: decreased 16.25% in 2023, then increased 17.69% in 2024.
- AC Immune's Assets Average stood at $283.2 million in 2020, then dropped by 3.32% to $273.8 million in 2021, then decreased by 12.98% to $238.3 million in 2022, then decreased by 16.25% to $199.6 million in 2023, then grew by 17.69% to $234.8 million in 2024.
- Per Business Quant, the three most recent readings for ACIU's Assets Average are $234.8 million (Q4 2024), $199.6 million (Q4 2023), and $238.3 million (Q4 2022).